Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by BrokerGon Apr 23, 2024 1:36pm
97 Views
Post# 36003628

RE:Cannabis Sector Green Today

RE:Cannabis Sector Green TodayEven to this day what I find amazing is that this stock pre-RS is only at $1.20. I know Q will have a conniption by me even saying this, but it is true, for the majority of us who purchased pre RS. The stock went to $70 on incredible hype and momentum yet we are now celebrating the stock at $1.20.

Can you imagine if institutions start buying again? We could hit $2.00 CDN, pre-RS. Sorry, lost in the past. We are now approaching month 8 since the HHS decision and recommendation, what is going on in the DEA? And why can't a sitting president, his VP, or even Congress ask them what the hold up is? Who is in charge of who? 
<< Previous
Bullboard Posts
Next >>